Posted by Michael Wonder on 06 Feb 2024
Chiesi Global Rare Diseases announces Health Canada approval of Myalepta (metreleptin for injection) for the treatment of patients with lipodystrophy
5 February 2024 - Canadian patients living with this ultra-rare condition welcome this new treatment option.
Chiesi Global Rare Diseases is pleased to announce the Health Canada approval of Myalepta (metreleptin for injection).
